SCHEMBL27180759

SCHEMBL27180759

O=C(Nc1cccc(S(=O)(=O)Nc2ccccc2F)c1)c1ccco1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.65
▸ MAPK1 P28482 5/20 0.65
▸ ALDH1A1 P00352 6/20 0.60
▸ MEN1 O00255 5/20 0.60
▸ KMT2A Q03164 5/20 0.60
▸ APOBEC3G Q9HC16 4/20 0.60
▸ SMN1; SMN2 Q16637 2/20 0.60
▸ LMNA P02545 5/20 0.59
▸ POLB P06746 1/20 0.59
▸ NPY1R P25929 1/20 0.59
▸ NPY2R P49146 1/20 0.59
▸ HPGD P15428 2/20 0.58
▸ PKM P14618 1/20 0.58
▸ MPI P34949 1/20 0.58
▸ RAB9A P51151 3/20 0.54
▸ KCNK3 O14649 1/20 0.53
▸ KCNK9 Q9NPC2 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.51
▸ USP2 O75604 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30926780 1.00 MAPT (0.65) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL30926930 0.79 NPSR1 (0.76) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL27180972 0.79 NPSR1 (0.76) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL20063247 0.78 MEN1 (0.60) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL30926895 0.78 MEN1 (0.60) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL30926551 0.78 MAPT (0.66) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL27179808 0.78 MAPT (0.66) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL30926893 0.77 KMT2A (0.59) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL27180073 0.77 KMT2A (0.59) MAPTMAPK1ALDH1A1MEN1KMT2A
SCHEMBL30926823 0.77 MAPT (0.60) MAPTMAPK1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MAPT 4236/4885MAPK1 2851/4885ALDH1A1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback